| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) | 
|---|
| 06/10/1993 | WO1993011232A1 Ifn-gamma antagonist cytokine | 
| 06/10/1993 | WO1993011231A1 Tools for the diagnosis and treatment of alzheimer's disease | 
| 06/10/1993 | WO1993011229A1 Novel polypeptides for promoting cell attachment | 
| 06/10/1993 | WO1993011219A1 Novel adherent and invasive mycoplasma | 
| 06/10/1993 | WO1993011162A1 Bispecific antibody heterodimers | 
| 06/10/1993 | WO1993011157A1 MALARIAL VACCINE AND PEPTIDES COMPRISING HUMAN T-CELL EPITOPE OF CIRCUMSPOROZOITE PROTEIN OF $i(P.VIVAX) | 
| 06/10/1993 | WO1993011155A1 Fragments of prion proteins | 
| 06/10/1993 | WO1993011153A1 Peptides and antibodies for treatment of rheumatoid arthritis | 
| 06/10/1993 | WO1993010817A1 CDw52-SPECIFIC ANTIBODY FOR TREATMENT OF MULTIPLE SCLEROSIS | 
| 06/10/1993 | WO1993010816A1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses | 
| 06/10/1993 | WO1993010815A1 Non-capsulated mutants of bacteria useful as vaccines | 
| 06/10/1993 | WO1993010814A1 Anti-cancer immunotherapeutic vector constructs | 
| 06/10/1993 | WO1993010808A1 INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX | 
| 06/10/1993 | WO1993010805A1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor | 
| 06/10/1993 | WO1993010798A1 Monoclonal antibody directed against g-cam and method of using it | 
| 06/10/1993 | WO1993010763A1 Antitumor vaccines | 
| 06/10/1993 | CA2125298A1 Tools for the diagnosis and treatment of alzheimer's disease | 
| 06/10/1993 | CA2124948A1 Gamma ifn-antagonist cytokine | 
| 06/10/1993 | CA2124848A1 Novel adherent and invasive mycoplasma | 
| 06/10/1993 | CA2124691A1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses | 
| 06/10/1993 | CA2124591A1 Inhibiting transforming growth factor .beta. to prevent accumulation of extracellular matrix | 
| 06/10/1993 | CA2123894A1 Bispecific antibody heterodimers | 
| 06/10/1993 | CA2123804A1 Recombinant viruses comprising artificial proteolytic cleavage site | 
| 06/10/1993 | CA2123694A1 Peptides and antibodies for treatment of rheumatoid arthritis | 
| 06/10/1993 | CA2084746A1 Prp overproducing haemophilus influenzae strain | 
| 06/09/1993 | EP0545016A1 Composition for nucleic acid complex transfer in suspension eukaryotic cells | 
| 06/09/1993 | EP0544942A1 Novel tools for the diagnosis and treatment of Alzheimer disease | 
| 06/09/1993 | EP0544838A1 Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines | 
| 06/09/1993 | EP0544815A1 Peptides from the GMP-140 lectinbindingdomain and selectin binding ligands on carbonhydrates | 
| 06/09/1993 | EP0544743A1 Lymphokine 154 | 
| 06/09/1993 | EP0544685A1 Mycobacterial expression vector | 
| 06/09/1993 | EP0463061B1 Controlled release delivery device for macromolecular proteins | 
| 06/09/1993 | EP0368920B1 Lectines fixing beta-d-galactoside | 
| 06/09/1993 | EP0327648B1 Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient | 
| 06/09/1993 | EP0250502B1 A process for inactivating thermally sensitive, pathogenic, blood-carried vira in igg preparations | 
| 06/09/1993 | EP0134242B1 Protective peptide antigen | 
| 06/09/1993 | CN1072862A Manufacturing method of medicament for therapy of hermorhoidal anus and intestinal diseases | 
| 06/08/1993 | US5218128 Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom | 
| 06/08/1993 | US5218099 Pure polynucleotide complimentary to or the same as specified DNA sequence | 
| 06/08/1993 | US5218001 Inhibitors of the advanced glycosylation of proteins and methods of use therefor | 
| 06/08/1993 | US5217898 Expression of the P. falciparum transmission-blocking antigen in yeast | 
| 06/08/1993 | US5217895 Neutralization of aids; diagnosis and(or) therapy | 
| 06/08/1993 | US5217872 Diagnosing Lymes disease | 
| 06/08/1993 | US5217868 Measurement of an enzyme marker as an aid to diagnosis of liver transplant rejection | 
| 06/07/1993 | CA2057213A1 Trophoblast interferon | 
| 06/02/1993 | EP0544612A2 Composition comprising an immunogen and a triglyceride | 
| 06/02/1993 | CN1072687A Anti-alphab-integrin antibodies | 
| 06/01/1993 | USH1198 Pseudomonas aeruginosa type-specific human monoclonal antibodies, their preparation and use | 
| 06/01/1993 | US5216128 IFN-β2/IL-6 receptor its preparation and pharmaceutical compositions containing it | 
| 06/01/1993 | US5215914 Adherent and invasive mycoplasma | 
| 06/01/1993 | US5215913 IgG-1 human monoclonal antibody reactive with an HIV-1 antigen and methods of use | 
| 06/01/1993 | US5215745 Administering avian paramyxovirus to increase the number of T-4 helper-inducer T cells in the infected patient | 
| 06/01/1993 | CA1318666C Immunostimulating guanine derivatives, compositions and methods | 
| 06/01/1993 | CA1318615C Radiohalogenated compounds for site specific labeling | 
| 05/27/1993 | WO1993010246A1 Membrane expression of heterologous genes | 
| 05/27/1993 | WO1993010242A1 NOVEL HUMAN cdc25 GENES, ENCODED PRODUCTS AND USES THEREFOR | 
| 05/27/1993 | WO1993010239A2 Hepatitis-c virus testing | 
| 05/27/1993 | WO1993010238A1 Pneumococcal fimbrial protein a vaccines | 
| 05/27/1993 | WO1993010237A1 Recombinant vaccine against lyme disease | 
| 05/27/1993 | WO1993010236A1 Protein allergens of the species cynodon dactylon | 
| 05/27/1993 | WO1993010227A1 Transgenic animals lacking prion proteins | 
| 05/27/1993 | WO1993010225A1 Protease vaccine against heartworm | 
| 05/27/1993 | WO1993010219A1 Cellular composition for the treatment of human or animal organisms | 
| 05/27/1993 | WO1993010216A1 Gram-negative bacterial vaccines | 
| 05/27/1993 | WO1993010152A1 HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG | 
| 05/27/1993 | WO1993010134A1 Ganglioside analogs | 
| 05/27/1993 | WO1993009815A1 Specific tolerance in transplantation | 
| 05/27/1993 | WO1993009812A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES | 
| 05/27/1993 | WO1993009811A1 TYPE I AND TYPE II SURFACE ANTIGENS ASSOCIATED WITH $i(STAPHYLOCOCCUS EPIDERMIDIS) | 
| 05/27/1993 | WO1993009810A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses | 
| 05/27/1993 | WO1993009809A1 Pasteurella multocida toxoid vaccines | 
| 05/27/1993 | WO1993009808A1 METHODS FOR DETECTING AND ISOLATING uPA-R AND INHIBITING THE BINDING OF uPA TO uPA-R | 
| 05/27/1993 | WO1993009806A1 Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality | 
| 05/27/1993 | WO1993009805A1 Polar lipid composition of plant origin | 
| 05/27/1993 | WO1993009792A1 Chimeric mammals with human hematopoietic cells | 
| 05/27/1993 | WO1993006218A3 Chimeras of parainfluenza virus type 3 proteins f and hn as vaccines | 
| 05/27/1993 | CA2378820A1 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes | 
| 05/27/1993 | CA2123874A1 Methods for detecting and isolating upa-r and inhibiting the binding of upa to upa-r | 
| 05/27/1993 | CA2123675A1 Membrane expression of heterologous genes | 
| 05/27/1993 | CA2123585A1 Polar lipidic composition from plants | 
| 05/27/1993 | CA2123420A1 Protease vaccine against heartworm | 
| 05/27/1993 | CA2123320A1 Pasteurella multocida toxoid vaccines | 
| 05/27/1993 | CA2123228A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses | 
| 05/27/1993 | CA2123213A1 Ganglioside analogs | 
| 05/27/1993 | CA2123210A1 Protein allergens of the species cynodon dactylon | 
| 05/27/1993 | CA2123121A1 Recombinant vaccine against lyme disease | 
| 05/27/1993 | CA2122725A1 Chimeric mammals with human hematopoietic cells | 
| 05/26/1993 | EP0543091A2 Monoclonal antibody reacting with Pseudomonas aeruginosa | 
| 05/26/1993 | EP0542998A1 Vaccine and treatment method of human immunodeficiency virus infection | 
| 05/26/1993 | EP0542977A1 Oral composition based on an antibiotic material and clay | 
| 05/26/1993 | EP0542971A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-$g(b) SUPERFAMILY | 
| 05/26/1993 | EP0542970A1 Nucleotide and peptide sequences of an isolate of the hepatitis c virus, diagnostic and therapeutic applications thereof | 
| 05/26/1993 | EP0542949A1 Hepatitis a virus strain, method for the isolation of said virus strains and hepatitis a vaccines | 
| 05/26/1993 | EP0542920A1 Cannabinoid receptor | 
| 05/26/1993 | EP0542843A1 Cloning and expression of toxoplasma antigens and use of recombinant antigens | 
| 05/26/1993 | EP0542770A1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof | 
| 05/26/1993 | EP0542756A1 Method of introducing a peptide into the cytosol | 
| 05/26/1993 | EP0542753A1 Epitopes of the pre-s region of hepatitis b virus surface antigen | 
| 05/26/1993 | EP0167575B1 Cardiodilatine, a new peptide hormone and production process thereof | 
| 05/26/1993 | CN1072454A Recombinant avirulent salmonella antifertility vaccines |